Azzam Bilal Chamdy
Neng Nana
Nana Muazin
Dwi Wanna
Raul Delapena Setiawan
The relationship between the United States and the World Health Organization (WHO), a cornerstone of international public health for over seven decades, has reached a critical juncture. As a founding member of the WHO, the United States has historically served as one of the organization’s most significant financial and scientific pillars. Together, these entities have achieved monumental victories in the annals of medical history—from the total eradication of smallpox to sustained, global progress against polio, HIV, Ebola, influenza, tuberculosis, and the silent, growing threat of antimicrobial resistance.
However, the recent formal notification of the United States’ intent to withdraw from the organization has sent shockwaves through the international community. The WHO has publicly expressed deep regret over this decision, warning that it compromises the safety of both the American public and the global population. This article explores the friction between Washington and Geneva, the timeline of the COVID-19 response, and the broader implications for the future of global pandemic preparedness.
1. The Core of the Dispute: Sovereignty and Accountability
The U.S. government’s decision to sever ties was predicated on a series of sharp criticisms, most notably the allegation that the WHO had "trashed and tarnished" the U.S. reputation, acted with bias, and compromised its own institutional independence. Specifically, Washington characterized the WHO as having succumbed to a "politicized, bureaucratic agenda" driven by nations perceived as hostile to American interests.
The WHO, through its official channels, has categorically rejected these assertions. "The reverse is true," the organization stated in a recent press release, emphasizing that it has consistently engaged with the United States in good faith, maintaining full respect for American sovereignty as it does with all 194 of its Member States. The WHO maintains that as a specialized agency of the United Nations, its governance structure is designed to be impartial, serving the health needs of all nations without fear or favor.
The U.S. further alleged that the WHO failed during the COVID-19 pandemic by "obstructing the timely and accurate sharing of critical information" and concealing institutional failures. These claims form the crux of the diplomatic rift, turning a technical debate over pandemic management into a fundamental disagreement over the efficacy of multilateral institutions.
2. A Chronology of the COVID-19 Response
To address the accusations of negligence, it is essential to revisit the initial trajectory of the COVID-19 crisis. The WHO asserts that its response was characterized by speed, transparency, and an unwavering reliance on the best available scientific evidence.
The Opening Phase (December 2019 – January 2020)
- December 31, 2019: The WHO receives the first reports of a cluster of "pneumonia of unknown cause" in Wuhan, China. The organization immediately requests further information and activates its emergency incident management system.
- January 11, 2020: Following the first reported death in China, the WHO alerts the global community through formal notification channels, social media, and public statements. It simultaneously convenes a group of international experts to formulate guidance for health systems.
- January 30, 2020: The Director-General declares COVID-19 a Public Health Emergency of International Concern (PHEIC). At this juncture—the highest level of alarm under international law—there were fewer than 100 cases reported outside of China and zero recorded deaths.
The Escalation (February – March 2020)
Throughout the early months of the pandemic, the WHO leadership issued repeated, urgent warnings. The Director-General frequently characterized the window of opportunity for containment as "closing," famously noting that "this is not a drill" and labeling the virus "public enemy number one."
The WHO maintains that its guidance throughout this period was evidence-based. It advocated for the utility of masks, vaccines, and physical distancing; however, the organization clarifies that it never recommended mandates for masks or vaccines, nor did it endorse lockdowns. Instead, the WHO supported sovereign governments in making policy decisions tailored to their specific domestic contexts, emphasizing that the final authority remained with national leadership.
3. Strengthening Systems: Lessons from the Pandemic
In the wake of multiple independent reviews of its performance during the pandemic, the WHO has undergone a period of introspection and institutional reform. The organization has taken concrete steps to bolster its internal operations and to assist Member States in strengthening their own national pandemic preparedness capacities.
These systems, which function on a 24/7 basis, are designed to detect emerging health threats before they escalate into global crises. By managing these networks, the WHO argues that it continues to provide a vital service to all countries, including the United States. The organization remains committed to the principle that global health security is collective; an outbreak anywhere is a threat everywhere.
4. The Path Ahead: The Pandemic Agreement
Despite the U.S. withdrawal notification, the WHO continues to push forward with its core mandate. The organization emphasizes that the vast majority of its Member States remain committed to multilateral cooperation. A landmark achievement in this regard was the adoption of the WHO Pandemic Agreement last year. Once fully ratified, this instrument will serve as a cornerstone of international law, creating a framework to keep the world safer from future pandemics.
Furthermore, Member States are currently negotiating an annex to this agreement: the Pathogen Access and Benefit Sharing (PABS) system. If successfully implemented, this system will facilitate the rapid detection and sharing of pathogens with pandemic potential. Crucially, it seeks to guarantee equitable and timely access to medical countermeasures—including vaccines, diagnostics, and therapeutics—for all countries, regardless of their economic status.
The WHO views these efforts as essential to fulfilling its constitutional mandate: the highest attainable standard of health as a fundamental human right.
5. Official Responses and Future Implications
The notification of withdrawal has triggered a formal process. These issues are scheduled for deliberation by the WHO Executive Board at its regular meeting starting February 2, and subsequently by the World Health Assembly at its annual meeting in May 2026.
The Diplomatic and Public Health Fallout
The implications of the U.S. departure are profound. From a public health perspective, the loss of American technical expertise, funding, and scientific collaboration could diminish the WHO’s ability to conduct large-scale initiatives. From a diplomatic perspective, the withdrawal signals a potential shift away from the post-WWII consensus on international cooperation.
However, the WHO remains hopeful that the United States will eventually return to active participation. The organization’s rhetoric remains conciliatory, emphasizing that it continues to value the support and engagement of all its members.
"We hope that in the future, the United States will return to active participation in WHO," the organization stated. "Meanwhile, WHO remains steadfastly committed to working with all countries in pursuit of its core mission."
The Reality of Global Interdependence
The COVID-19 pandemic served as a stark reminder of the interconnected nature of the modern world. No country, regardless of its economic or military strength, can unilaterally secure its population against a global pathogen. The WHO asserts that its existence as a neutral, scientific, and technical forum is the only viable path toward addressing the world’s biggest health threats—both communicable, such as the next potential pandemic, and non-communicable, such as the global rise of cancer and cardiovascular disease.
As the world watches the unfolding situation, the debate serves as a litmus test for the future of global governance. The question remains: can the international system adapt to modern political pressures while maintaining the technical integrity required to protect human life on a global scale? For the WHO, the answer is a resolute commitment to its mandate, serving the global citizenry with or without the participation of its most powerful founding member.
In conclusion, while the rift between the U.S. and the WHO represents a significant challenge to global health infrastructure, both parties are effectively locked in a process of re-evaluating the terms of their engagement. As the Executive Board meets in the coming months, the international community will be closely watching to see how the organization balances the accusations of its critics with the necessity of maintaining a unified, global response to the health challenges of the 21st century.
